OSUCCC – James Cancer Diagnostic Center speeds up diagnosis, treatment

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A new center at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute gives patients direct, expedited access to diagnostic testing for cancer.

The center’s goal is to provide immediate community-wide patient access to cancer providers for anyone with a suspected cancer, especially in communities where access to healthcare is limited and has become more challenging during the COVID-19 pandemic.

The James Cancer Diagnostic Center offers a platform for expert evaluation and access to the appropriate diagnostic testing so that a cancer diagnosis can be made in a timely and precise manner, in a low-risk environment. Center visits can be virtual or in-person based on the patient’s preference.

Launched on June 15, the Cancer Diagnostic Center is open daily and staffed by a team of advanced practice professionals and nurses who have expertise in oncology. The team is overseen by physicians with oncology experience and expertise.

The center is available for both self- or physician-referral. Center staff first identify and prioritize patient needs and concerns and then coordinate appropriate testing and evaluation on behalf of the patient at facilities within The James and the Ohio State Wexner Medical Center. Follow-up care is also coordinated with a specialized, multidisciplinary team at The James if a cancer diagnosis is made.

Table of Contents

YOU MAY BE INTERESTED IN

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.
Michael R. Caputo, a cancer survivor and a Republican political operative with a wide-ranging resume, was named to the President’s Cancer Panel, a board formed under the National Cancer Act to monitor the National Cancer Program and report to the president about “barriers to progress in reducing the burden of cancer.”
For over two decades, the ASCO Genitourinary Cancers Symposiumhas stood as the premier global event that has helped advance cancer science and transform care. The 2027 Symposium will continue this legacy from Feb. 11–13 in San Francisco by bringing together the largest international audience in GU oncology to help define tomorrow’s standards of care. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login